The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...